California Cancer Reporting System Standards, Volume III

IF1111: CS SSF 1, TS/Ext Eval, Retinoblastoma Schema

OWNER

CS

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

CS Tumor Size/Ext Eval [NAACCR #2820]

CS Site-Specific Factor 1 [NAACCR# 2880]

CS Site-Specific Factor25 [NAACCR #2879]

CS Version Input Original [NAACCR #2935]

TABLE

None

MESSAGE

  1. IF 1111: If CS Tumor Size/Ext Eval = [value], CS Site-Specific Factor 1 must not = 970

  2. IF 1111: If CS Tumor Size/Ext Eval = [value], CS Site-Specific Factor 1 must not = 950

specification

For cases coded using the Retinoblastoma schema, if CS Tumor Size/Ext Eval indicates surgical resection (codes 3, 5, 6), then CS Site Specific Factor 1 (extension evaluated at enucleation) must not indicate "no enucleation performed" (code 970). If CS Tumor Size/Ext Eval = 6 (surgical resection performed WITH pre-surgical systemic treatment or radiation; tumor size and/or extension based on pathologic evidence), then CS Site Specific Factor 1 must not indicate "no evidence of primary tumor" (code 950).

This edit is skipped if any of the following conditions are true:

1.    CS Version Input Original is less than 020500

2.    CS Tumor Size/Ext Eval is blank

3.    CS Site-Specific Factor 1 is blank or 988

4.    CS schema is invalid

This edit first determines the CS schema by doing a function call to the CS Dynamic Link Library (dll).  The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

If schema is Retinoblastoma:

1. If CS Tumor Size/Ext Eval = 3, 5, 6 (codes indicating surgical resection), then CS Site Specific Factor 1 must not = 970 (no enucleation performed).

2. If CS Tumor Size/Ext Eval = 6 (surgical resection performed WITH pre-surgical systemic treatment or radiation; tumor size and/or extension based on pathologic evidence), then CS Site Specific Factor 1 must not = 950 (no evidence of primary tumor).

historical changes

In the SEER*Edits software, the title of this edit is: IF500.

04/2014

New edit added to NAACCR v14 metafile.